Herpes simplex keratitis

Indian Journal of Ophthalmology

Volumn 47, Issue 3, 1999, Pages 155-165

  Suresh, P S ^a   Tullo, Andrew B ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

Corneal stromal disease; Herpes simplex keratitis; Topical steroids; Unilateral blindess

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; CORTICOSTEROID; IDOXURIDINE; TRIFLURIDINE; VIDARABINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLINDNESS; CLINICAL FEATURE; CORNEA EPITHELIUM; CORNEA STROMA; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; IRIDOCYCLITIS; PATHOGENESIS; PENETRATING KERATOPLASTY; RECURRENT INFECTION; REVIEW; VIRUS CULTURE; VIRUS LATENCY; VIRUS REACTIVATION;

CORNEA; HERPESVIRUS 1, HUMAN; HUMANS; KERATITIS, HERPETIC;

EID: 0032868070     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Kaufman H, Centifanto-Fitzgerald Y, Varnell E. Herpes simplex keratitis. Ophthalmology 1983;90:700-6.
2. Centifanto-Fitzgerald Y, Fenger T, Kaufman HE. Virus protein in herpetic keratitis. Exp Eye Res 1982;35:425-41.
3. Smeraglia R, Hochadel J, Varnell ED, Kaufman HE, Centifanto-Fitzgerald Y. The role of herpes simplex virus secreted glycoproteins in herpetic keratitis. Exp Eye Res 1982;35:443-59.
4. Kaufman HE, Varnell ED, Centifanto-Fitzgerald Y, Kissling GE. Effect of the herpes simplex virus genome on the response of infection to corticosteroids. Am J Ophthalmol 1985;100:114-18.
5. Baringer JR, Swoveland P. Recovery of herpes simplex virus from human trigeminal ganglion. N Engl J Med 1973;288:648-50.
6. Tullo AB, Shimeld C, Blyth WA, Hill T, Easty DL. Spread of virus and distribution of latent infection following ocular herpes simplex in the non immune and immune mouse. J Gen Virol 1982;63:95-101.
7. Hill TJ. Ocular pathogenicity of herpes simplex virus. Curr Eye Res 1987;6:1-7.
8. Tullo AB, Easty D, Scimeld C, Stirling PE, Darville JM. Isolation of herpes simplex virus from corneal discs of patients with chronic stromal keratitis. Trans Ophthalmol Soc UK 1985;104:159-65.
9. Pavan Langston D, Rong B, Dinkel E. Extraneural herpetic latency. Animal and human corneal studies. Acta Ophthalmol (Copenh) 1989;67 (Suppl) :135-41.
10. Coupe D, Klapper PE, Cleator GM, Bailey AS, Tullo AB. Herpes simplex in chronic human stromal keratitis. Curr Eye Res 1986;5:735-38.
11. Cook SD. In vitro and in vivo ocular studies using HSV type 1 & 2.[PhD thesis]. Glasgow, UK: University of Glasgow. 1988.
12. Cook SD, Hill JH. Herpes Simplex Virus: Molecular biology and the possibility of corneal latency. Surv Ophthalmol 1991;36:141-48.
13. Van Horne DL, Edelhauser HF, Schultz RO. Experimental herpes simplex keratitis. Early alteration of corneal epithelium and stroma. Arch Ophthalmol 1970;84:67-75.
14. Baum J. Morphogenesis of the dendritic figure in herpes simplex keratitis. Am J Ophthalmol 1972;70:722-24.
15. Thygeson P. Marginal herpes simplex keratitis simulating catarrahal ulcer. Invest Ophthalmol 1971;10:1006.
16. Pavan Langston D. Viral Diseases of the cornea and external eye. In: Albert D, Jacobiec F, editors. Principles and Practice of Ophthalmology. Philadelphia, USA: WB Saunders Company; 1994. Vol 1, p126.
17. Hendricks RL. An immunologist's view of the herpes simplex keratitis. Cornea 1997;16:503-6.
18. Mayers-Elliot R, Pettit T, Maxwell W. Viral antigens in the immune ring of herpes simplex stromal keratitis. Arch Ophthalmol 1980;98:897-904.
19. Kaufman H. Epithelial erosion syndrome: metaherpetic keratitis. Am J Ophthalmol 1964;57:983-87.
20. Boisjoly HM, Pavan Langston D, Kenyon KR, Baker AS. Superinfection in Herpes simplex keratitis. Am J Ophthalmol 1983;96:354-61.
21. Jones BR, Falcon MG, William HP, Coster DJ. Symposium on herpes simplex eye disease. Trans Ophthalmol Soc UK 1977;97:305-13.
22. Hendricks RL, Epstein RJ, Tumpey T. The effects of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis. Invest Ophthalmol Vis Sci 1989;30:105-15.
23. Holbach LM, Font RL, Naumann GOH. Herpes simplex stromal and endothelial keratitis. Ophthalmology 1990;97:722-23.
24. Oslen TW, Hardten DR, Meiusi RS, Holland EJ. Linear endotheliitis. Am J Ophthalmol 1994;117:468-74.
25. Robin JB, Steigner JB, Kaufman HE. Progressive herpetic corneal endotheliitis. Am J Ophthalmol 1985;100:336-37.
26. Hawkin KN, Dart JK, Sherrad E. Sporodic diffuse corneal endotheliitis. Am J Ophthalmol 1989;108:509-15.
27. Vannas A, Ahonen R. Herpetic endothelial keratitis. Acta Ophthalmol 1981;59:296-301.
28. Robin JB, Steigner JB, Kaufman HE. Progressive herpetic corneal endotheliitis. Am J Ophthalmol 1985;100:336-37.
29. Kaufman H, Kanai A, Ellison E. Herpetic iritis: Demonstration of virus in the anterior chamber by fluorescent antibody techniques and electron microscopy. Am J Ophthalmol 1971;71:465-69.
30. Sundmacher R, Neumann-Haefelin D. HSV isolation from the aqueous of patients suffering from focal iritis, endotheliitis and prolonged disciform keratitis with glaucoma. Klin Monatsbl Augenheilkd 1979;175:488-501.
31. Witmer R, Iwamoto T. Electron microscopic observation of herpetic particles in the iris. Arch Ophthalmol 1968;79:331-37.
32. Young TK, Robin JB, Holland GN, Hendricks RL, Paschal JF, Engstrom RE. Herpes simplex keratitis in patients with acquired immuodeficiency syndrome. Ophthalmology 1989;96: 1476-79.
33. Hodge WG, Margolis TP. Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus. Ophthalmology 1997;104:120-24.
34. Gebhardt BM, Reidy J, Kaufman HE. An affinity membrane test for superficial corneal herpes. Am J Ophthalmol 1988;105:686-87.
35. Kaufman HE, Nesburn AB, Maloney ED. IDU therapy of herpes simplex. Arch Ophthalmol 1962;67:583-91.
36. Gasset AR. Katzin D. Antiviral drugs and corneal wound healing. Invest Ophthalmol 1975;14:628-30.
37. Longston RHS, Pavan-Langston D, Dohlman CH. Antiviral medication and corneal wound healing. Arch Ophthalmol 1974;92:509-13.
38. Kaufman HE, Martola EL, Dohlman C. Use of 5 Iodo-2′-deoxyuridine in treating herpes simplex keratitis. Arch Ophthalmol 1962;68:235-39.
39. Patterson A, Fox AD, Davies G, Maguire C, Ellers H, Wright P, et al. Controlled studies of IDU in the treatment of herpetic keratitis. Trans Ophthalmol Soc UK 1963;83:583-91.
40. Hart DR, Brightman VJF, Readshaw GG, Porter GTJ, Tully MJ. Treatment of human herpes simplex keratitis with idoxuridine. Arch Ophthalmol 1965;73:623-34.
41. Itoi M, Gefter JW, Keneko N, Ishii Y, Ramer RM, Gasset AR. Teratogenecity of Ophthalmic drugs. Arch Ophthalmol 1975;93:46-51.
42. Laibson PR. Current therapy of Herpes simplex virus infection of the cornea. Invest Ophthalmol 1973;13:39-52.
43. Markham RHC, Carter C, Scobie MA, Metcalf C, Easty DL. Double blind clinical trail of adenine arabinoside and idoxuridine in herpetic corneal ulcers. Trans Ophthalmol Soc UK 1977;97:333.
44. Pavan Langston D, Buchanan RA. Vidarabine therapy of Herpetic keratitis. Trans Am Acad Ophthalmol Otolaryngol 1976;81:813-25.
45. Wellings PC, Awdry PN, Bors F, Jones BR. Clinical evaluation of triflurothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol 1972;73:932-42.
46. Collum L. Randomised double blind trail of acyclovir and idoxuridine in dendritic corneal ulceration. Br J Ophthalmol 1980;64:766-69.
47. Pavan Langston D, Foster CS. Triflurothymidine and IDU therapy of ocular Herpes. Am J Ophthalmol 1977;84:818-25.
48. McGill J, Holt Wilson D, Mckinnon JR, Williams HP, Jones BR. Clinical use of Trifluothymidine in the treatment of herpetic ulceration of cornea. Trans Ophthalmol Soc UK 1974;94:342-52.
49. Polrier R H, Kingham JD, Paulo de Mirande, Annel M. Intraocular antiviral penetration. Arch Ophthalmol 1982;100:1964-67.
50. Pavan Langston D, Lass J, Whetting M, Duel I: Acyclovir and vidarabine in therapy of ulcerative herpes simplex keratitis. Am J Ophthalmol 1981;92:829-35.
51. Maudgal P, De Clercque E, Missotten L. Efficacy of bromovinl deoxyuridine in the treatment of herpes simplex virus and varicella zoster eye infection. Antiviral Res 1984;4:281-91.
52. Colin J, Bing Hoh H, Easty DL, Herbort CP, Resnikoff S, Rigal D, Romdane K. Ganciclovir ophthalmic gel in the treatment of herpes simplex keratitis. Cornea 1997;16:393-99.
53. Kibrick S, Takahasai GA, Leibowitz HM, Laibson PR. Local corticosteroid therapy and reactivation of herpetic keratitis. Arch Ophthalmol 1971;86:694-98.
54. Meisler DM, Langston RHS, Naab TJ, Aaby AA, McMahon J, Tubbs RR. Infectious crystalline keratopathy. Am J Ophthamol 1984;97:337-43.
55. Hung SO, Patterson A, Rees PJ. Oral acyclovir in the management of dendritic herpetic corneal ulceration. Br J Ophthalmol 1984;68:698-400.
56. Collum LMT, Akhtar J, McGettrick P. Oral acyclovir in herpetic keratitis. Trans Ophthalmol Soc UK 1985;104:629-32.
57. Schwab I. Oral acyclovir in the management of herpes simplex ocular infections. Ophthalmology 1988;95:423-30.
58. Costner DJ, Jones B, Falcon MG. Role of debridement in the treatment of herpetic keratitis. Trans Ophthalmol Soc UK 1977;97:314-17.
59. Wilhelmus KR, Gee L, Hauck WH, Kurinij N, Dawson CR, Jones DB, et al. Herpetic eye disease study, a controlled trail of topical corticosteroids for herpes simplex stromal keratitis. Ophthalomology 1994;101:1883-96.
60. Williams HP, Falcon MG, Jones BR. Corticosteroids in the management of herpetic eye disease. Trans Ophthalmol 1977;97:341-44.
61. Barran BA, Gee L, Hauck WH, Kurinij N, Dawson CR, Jones DB. Herpetic eye disease study. A controlled trail of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 1994;101:1871-82.
62. Foster MD, Duncan BA. Penetrating keratoplasty for herpes simplex keratitis. Am J Ophthalmol 1981;92:336-43.
63. Cobo, Coster DJ, Rice NS, Jones BR. Prognosis and management of corneal transplantation for herpetic keratitis. Arch Ophthalmol 1980;98:1755-59.
64. Fine M, Cignetti FE. Penetrating keratoplasty in herpes simplex keratitis. Arch Ophthalmol 1977;95:613-17.
65. Langston R, Pavan Langston D, Dohlman CH. Penetrating keratoplasty for herpetic keratitis. Prognostic and therapeutic determinants. Trans Am Acad Ophthalmol 1975;79:577-83.
66. Ficker LA, Kirkness CM, Rice NSC, McG Steele AD. Long term prognosis for corneal grafting in herpes simplex keratitis. Eye 1988;2:400-8.
67. Cleator GM, Klapper PE, Dennett C, Sullivan AL, Bonshek RE, Marcynuk B, Tullo AB. Corneal donor infection by herpes simplex virus: HSV DNA in donor corneas. Cornea 1994;13:294-304.
68. Mannis MJ, Plotnik RD, Schwab IR, Newton RD. Herpes simplex dendritic keratitis after keratoplasty. Am J Ophthalmol 1991;111:430-84.
69. Beyer CF, Byrd TJ, Hill JM, Kaufman HE. Herpes simplex virus and persistent epithelial defects after penetrating keratoplasty. Am J Ophthalmol 1990;109:95-96.
70. Remeijev L, Doornenbal P, Geerads AJM, Rijneveld WA, Beekhuis WH. Newly acquired herpes simplex keratitis after penetrating keratoplasty. Ophthalmology 1997;104:648-52.
71. Moyes AL, Sugar A, Musch DC, Barns RD. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 1994;112:601-7.
72. Spruance SL, Stewart J, Rowe N, Mc Keough MG, Wenerstrom G, Freeman DJ. Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis 1990;161:185-90.
73. Kaplowitz LG, Baker D, Gelle L. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex infection. JAMA 1991;265:747-51.
74. The Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Eng J Med 1998;339:300-6.
75. Barney NP, Foster CS. A prospective randomised trail of acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 1994;13:232-36.
76. Vail A, Gore SM, Bradley BA, Easty DL, Rogers CA, Armitage WJ. Influence of donor and histocompatibility factors on corneal graft outcome. Transplantation 1994;58:1210-16.
77. Cheng C, Chang S, Hu F. Acyclovir treatment for linear endotheliitis on grafted corneas. Cornea 1995;14:311-15.